Chau Nguyen-Tran, MD
Obstetrics & Gynecology · Sugar Land, TXNPI 1568464840
Payments from drug & device makers
Across 218 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$717
- Sumitomo Pharma America, Inc.$457
- Mayne Pharma Commercial LLC$371
- Astellas Pharma US Inc$320
- Bayer$249
- Sage Therapeutics, LLC$224
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,10597%
- Education$1052%
- Entertainment$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $717 |
| Sumitomo Pharma America, Inc. | 26 | $457 |
| Mayne Pharma Commercial LLC | 16 | $371 |
| Astellas Pharma US Inc | 13 | $320 |
| Bayer | 11 | $249 |
| Sage Therapeutics, LLC | 9 | $224 |
| Exeltis, USA Inc. | 9 | $183 |
| Radius Health, Inc. | 8 | $151 |
| Myovant Sciences Inc. | 7 | $143 |
| Amgen | 6 | $124 |
| Coopersurgical, Inc. | 7 | $118 |
| Exact Sciences | 5 | $99 |
| Organon | 5 | $92 |
| Millicent US Inc | 4 | $80 |
| Avion Pharmaceuticals | 5 | $74 |
| Merck | 4 | $72 |
| Pfizer | 4 | $69 |
| Evofem Biosciences, Inc. | 3 | $64 |
| LSI Solutions Inc | 1 | $60 |
| Shield Therapeutics Inc | 3 | $57 |
| Davol Inc. | 1 | $51 |
| Hologic Sales And Service, LLC | 2 | $48 |
| Lupin Inc. | 2 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Mylan Pharmaceuticals Inc. | 2 | $35 |
| Medtronic | 2 | $33 |
| Therapeuticsmd, Inc. | 2 | $31 |
| Gynesonics, Inc. | 1 | $27 |
| Molnlycke Health Care US, LLC | 1 | $25 |
| Smith+Nephew | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
| Aspira Women's Health Inc | 1 | $20 |
| Optumhealth Care Solutions, LLC | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $15 |
| Argentum Medical | 1 | $13 |
| Medicem Inc. | 1 | $13 |
| Scynexis, Inc. | 1 | $12 |
| Alvogen Inc | 1 | $12 |
| Renovia Inc | 1 | $11 |
| Acessa Health Inc. | 1 | $11 |
How this compares
$4,223 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 42 | $1,241 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $247 |
| Alendronate Sodium | 24 | $213 |
| Fluconazole | 16 | $38 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Sugar Land
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
- Dawnette PepplerArlington$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.